(Press-News.org) The Advanced Research Projects Agency for Health (ARPA-H) has appointed Etta D. Pisano, MD, FACR, senior portfolio lead, to build the agency's clinical trial portfolio and lead the ARPA-H Advancing Clinical Trials Readiness Initiative under ARPA-H Resilient Systems Mission Office Director Jennifer Roberts.
The first radiologist to be appointed to such a role, Dr. Pisano is an internationally recognized expert in women's health, breast cancer research, and the use of artificial intelligence in medical imaging applications.
"I am honored to be working for ARPA-H to identify and promote research that can improve healthcare quality, efficacy and delivery, and to improve patient care and access to clinical trials for all Americans, including women, rural residents, and the underserved," said Dr. Pisano.
Dr. Pisano will continue to serve as study chair of the large-scale Tomosynthesis Mammographic Imaging Screening Trial (TMIST) for the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN). TMIST is led by ECOG-ACRIN with funding from the National Cancer Institute, part of the National Institutes of Health. She will also continue to serve as the American College of Radiology® (ACR®) Chief Research Officer (CRO). Dr. Pisano previously served as the principal investigator of the landmark Digital Mammographic Imaging Screening Trial (DMIST).
The TMIST breast cancer screening study is among the fastest growing National Cancer Institute (NCI) trials of the COVID-19 era. Under Dr. Pisano's leadership, TMIST is assembling one of the most diverse cancer screening trial populations ever. Approximately 21% of TMIST U.S. participants are Black—more than double the average rate for Black participation in NCI-funded clinical trials (9%).
With ARPA-H, Dr. Pisano will work to build underserved and minority participation in clinical trials—including identifying and onboarding rural facilities and those outside of large academic medical centers—such as emerging retail healthcare sites.
These duties are also very consistent with the missions of ECOG-ACRIN and ACR, which include promoting the exploration and identification of next-generation technologies that can benefit patients and providers.
"This is a great opportunity for Etta, and I'm excited about the impact she will make on our approach to clinical trials," said Mitchell D. Schnall, MD, PhD, group co-chair of ECOG-ACRIN.
About ECOG-ACRIN
The ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) is an expansive membership-based scientific organization that designs and conducts cancer research involving adults who have or are at risk of developing cancer. The Group comprises nearly 1400 member institutions and 21,000 research professionals in the United States and around the world. ECOG-ACRIN is known for advancing precision medicine and biomarker research through its leadership of major national clinical trials integrating cutting-edge genomic approaches. Member researchers and advocates collaborate across more than 40 scientific committees to design studies spanning the cancer care spectrum, from early detection to management of advanced disease. ECOG-ACRIN is funded primarily by the National Cancer Institute, part of the National Institutes of Health. Visit ecog-acrin.org, and follow us on X @eaonc, Facebook, LinkedIn, and Instagram.
Media Contact: Diane Dragaud, Director of Communications, communications@ecog-acrin.org.
END
ARPA-H appoints Etta Pisano to lead its Advancing Clinical Trials Readiness Initiative
An internationally recognized expert in women's health, breast cancer research, and the use of AI in medical imaging, she will identify and promote research to improve healthcare for all Americans, including women, rural residents, and the underserved
2024-03-20
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Quantum tornado provides gateway to understanding black holes
2024-03-20
Scientists have for the first time created a giant quantum vortex to mimic a black hole in superfluid helium that has allowed them to see in greater detail how analogue black holes behave and interact with their surroundings.
Research led by the University of Nottingham, in collaboration with King’s College London and Newcastle University, have created a novel experimental platform: a quantum tornado. They have created a giant swirling vortex within superfluid helium that is chilled to the lowest possible temperatures. Through the observation of minute wave dynamics on the superfluid’s surface, the research team has shown that these quantum ...
Introducing Floorlocator: a game-changer in indoor navigation technology
2024-03-20
Researchers have developed FloorLocator, a breakthrough in indoor navigation technology, which combines the high efficiency of Spiking Neural Networks (SNNs) with the advanced learning capabilities of Graph Neural Networks (GNNs). This innovative approach ensures remarkable accuracy and scalability for floor localization, crucial for enhancing emergency responses, indoor positioning, and personalized recommendation systems.
Indoor positioning is transforming with applications demanding precise location tracking. Traditional methods, including fingerprinting and sensor-based techniques, though widely used, face significant drawbacks such as the ...
New survey on deep learning solutions for cellular traffic prediction
2024-03-20
The bustling streets of a modern city are filled with countless individuals using their smartphones for streaming videos, sending messages and browsing the web. In the era of rapidly expanding 5G networks and the omnipresence of mobile devices, the management of cellular traffic has become increasingly complex. To address this challenge, mobile network operators need methods for the accurate prediction of cellular traffic. A comprehensive survey published 5 Jan. in Intelligent Computing explores deep learning techniques for cellular traffic prediction.
Better cellular traffic prediction would enhance intelligent 5G network construction and resource management, thereby ...
Cellular architecture of lesions in MS now mapped out
2024-03-20
Using advanced methodology, scientists in Sweden were able to reveal at the cellular level how lesions in multiple sclerosis develop. The new results are presented in the journal Cell by researchers from Karolinska Institutet and Stockholm University.
Over 1,8 million people worldwide are diagnosed with multiple sclerosis, MS. In this disease, the body's immune cells attack the cells that form myelin, the so-called oligodendrocytes, which belong to the group of glial cells. Without myelin, signals between nerve cells cannot travel as fast as ...
ADHD medications and work disability and mental health outcomes
2024-03-20
About The Study: In this Swedish nationwide cohort study of 221,000 individuals with attention-deficit/hyperactivity disorder (ADHD), the use of ADHD medication was associated with fewer hospitalizations for both psychiatric and non-psychiatric morbidity and lower suicidal behavior.
Authors: Heidi Taipale, Ph.D., of the Karolinska Institutet in Stockholm, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2024.2859)
Editor’s Note: Please see the article for additional information, including ...
Electrocardiographic findings in female professional basketball athletes
2024-03-20
About The Study: This study that included 173 Women’s National Basketball Association athletes provides reference electrocardiographic (ECG) data for elite female basketball athletes. International criteria–defined training-related findings were common, whereas abnormal ECG findings were rare in this athlete group. These reference data may assist basketball programs and health care professionals using ECGs in screening for female athletes and may be used as a stimulus for future female-specific ECG ...
Experts warn climate change will fuel spread of infectious diseases
2024-03-20
A team of infectious diseases experts called for more awareness and preparedness in the medical field to deal with the impact of climate change on the spread of diseases. Their article, published today in JAMA raises the alarm about the emergence and spread of harmful pathogens. The authors also urge the medical community to update their education and training and take steps to combat global warming.
“Clinicians need to be ready to deal with the changes in the infectious disease landscape,” said lead author George R. Thompson. Thompson is a professor at the UC Davis School of Medicine in the Department of Internal Medicine, Division of Infectious Diseases, and the ...
Researchers report on the effectiveness of skin biopsy to detect Parkinson’s and related neurodegenerative diseases
2024-03-20
BOSTON – In a paper published in the Journal of the American Medical Association (JAMA), neurologists at Beth Israel Deaconess Medical Center (BIDMC) showed that a simple skin biopsy test detects an abnormal form of alpha-synuclein, the pathological hallmark of Parkinson’s disease and the subgroup of neurodegenerative disorders known as synucleinopathies, at high positivity rates. Results from this landmark study sponsored by the National Institutes of Health (NIH) validate this cutaneous method as a reliable and convenient tool to help physicians make more accurate diagnoses ...
Treating anxiety, depression in people with heart disease reduced ER visits, hospitalizations
2024-03-20
Research Highlights:
Treating anxiety and depression significantly reduced hospital readmission and emergency room visits in people with heart disease.
This may be the first study to show that treating anxiety and depression with medication or psychotherapy has a significant impact on heart disease outcomes.
People with heart disease who are also diagnosed with anxiety or depression may benefit from mental health treatment to improve cardiovascular outcomes, the study researchers noted.
Embargoed until 4 a.m. CT/5 a.m. ET Wednesday, ...
Manager of Cancer Care Equity Program for NCCN named to ‘40 Under 40’ list from National Minority Quality Forum
2024-03-20
PLYMOUTH MEETING, PA [March 20, 2024] — The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers—is pleased to announce that Taneal D. Carter, MS, MPA, has been named one of 2024’s ‘40 Under 40’ by the National Minority Quality Forum (NMQF). Every year, NMQF selects 40 health leaders from minoritized populations under the age of 40 who have been leading the charge to better patient outcomes and build sustainable healthy communities. These 40 leaders have persevered in strengthening their communities and reducing health disparities amid ongoing ...
LAST 30 PRESS RELEASES:
Patrick Tan appointed as Duke-NUS Dean to lead next era of medical innovation and education
Development of a novel modified selective medium cefixime–tellurite-phosphate-xylose-rhamnose MacConkey agar for isolation of Escherichia albertii and its evaluation with food samples
KIST develops full-color-emitting upconversion nanoparticle technology for color displays with ultra-high color reproducibility
Towards a fully automated approach for assessing English proficiency
Increase in alcohol deaths in England an ‘acute crisis’
Government urged to tackle inequality in ‘low-carbon tech’ like solar panels and electric cars
Moffitt-led international study finds new drug delivery system effective against rare eye cancer
Boston stroke neurologist elected new American Academy of Neurology president
Center for Open Science launches collaborative health research replication initiative
Crystal L. Mackall, MD, FAACR, recognized with the 2025 AACR-Cancer Research Institute Lloyd J. Old Award in Cancer Immunology
A novel strategy for detecting trace-level nanoplastics in aquatic environments: Multi-feature machine learning-enhanced SERS quantification leveraging the coffee ring effect
Blending the old and the new: Phase-change perovskite enable traditional VCSEL to achieve low-threshold, tunable single-mode lasers
Enhanced photoacoustic microscopy with physics-embedded degeneration learning
Light boosts exciton transport in organic molecular crystal
On-chip multi-channel near-far field terahertz vortices with parity breaking and active modulation
The generation of avoided-mode-crossing soliton microcombs
Unlocking the vibrant photonic realm: A new horizon for structural colors
Integrated photonic polarizers with 2D reduced graphene oxide
Shouldering the burden of how to treat shoulder pain
Stevens researchers put glycemic response modeling on a data diet
Genotype-to-phenotype map of human pelvis illuminates evolutionary tradeoffs between walking and childbirth
Pleistocene-age Denisovan male identified in Taiwan
KATRIN experiment sets most precise upper limit on neutrino mass: 0.45 eV
How the cerebellum controls tongue movements to grab food
It’s not you—it’s cancer
Drug pollution alters migration behavior in salmon
Scientists decode citrus greening resistance and develop AI-assisted treatment
Venom characteristics of a deadly snake can be predicted from local climate
Brain pathway links inflammation to loss of motivation, energy in advanced cancer
Researchers discover large dormant virus can be reactivated in model green alga
[Press-News.org] ARPA-H appoints Etta Pisano to lead its Advancing Clinical Trials Readiness InitiativeAn internationally recognized expert in women's health, breast cancer research, and the use of AI in medical imaging, she will identify and promote research to improve healthcare for all Americans, including women, rural residents, and the underserved